AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Alzex Neuropharma Inc.

$0.00 +$0.00 (+100.00%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00$0.00
Year Range
$0.00$0.00
Market Cap
602
AVG Volume
10
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-300K-200K-100K022 Q423 Q123 Q223 Q3
TRRI Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
23 Q3-211.54K
23 Q2-222.34K
23 Q1-213.82K
22 Q4-166.05K
Operating Income (USD) · TTM
-300K-200K-100K022 Q423 Q123 Q223 Q3
TRRI Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
23 Q3-206.17K
23 Q2-217.3K
23 Q1-210.57K
22 Q4-164.57K
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Alzex Neuropharma Inc.
TRRI
Stockpicker

Video analysis: TRRI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TRRI

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.